Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    This update changes only the revision history: a new Revision v3.3.2 was added and Revision v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:24:44.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The operating-status notice about government funding was removed from the page, and the standard study information is now displayed.
    Difference
    0.8%
    Check dated 2025-11-17T18:51:56.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-11-03T13:16:55.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and updated version to v3.2.0; removed the previous version tag v3.1.0.
    Difference
    13%
    Check dated 2025-10-06T01:53:17.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.3%
    Check dated 2025-09-28T23:28:35.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, signaling a new release; the Back to Top link has been removed as a minor navigation change.
    Difference
    0.8%
    Check dated 2025-09-14T09:47:14.000Z thumbnail image

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.